Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

POTEJ Inhibitors

If POTEJ inhibitors were to exist as a chemical class, they would be compounds designed to bind selectively to the POTEJ protein or enzyme, assuming POTEJ is a biological molecule involved in a cellular process. The inhibitors would function by specifically interacting with this protein, potentially obstructing its active site or altering its structure in such a way as to prevent its normal operation. The development of these inhibitors would be based on a profound understanding of the POTEJ's three-dimensional configuration, which would likely be elucidated through high-resolution structural biology techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryogenic electron microscopy (cryo-EM). These techniques would reveal the intricacies of the protein's active site and potential allosteric sites, which are areas where an inhibitor can bind to influence the protein's activity.

The process of discovering and refining POTEJ inhibitors would involve the synthesis and characterization of potential inhibitory compounds followed by a cycle of testing and modification. Chemists would use insights from structural studies to predict how different chemical structures might interact with the POTEJ protein. Computational methods, including molecular docking and dynamics simulations, would play an integral role in forecasting the affinity and specificity of potential inhibitors to the POTEJ protein. The goal in designing these molecules would be to achieve a snug fit and strong interaction with the protein, typically through a combination of hydrophobic interactions, hydrogen bonds, and van der Waals forces. The optimization process would focus on enhancing these molecular interactions to produce potent and selective inhibitors. The physicochemical properties of these compounds, such as solubility, stability, and conformational rigidity or flexibility, would also be fine-tuned to improve their interaction with the target protein, all the while ensuring they maintain a high level of specificity to reduce the likelihood of off-target effects.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Vorinostat inhibits histone deacetylases (HDACs), leading to a more open chromatin structure and altered gene expression.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

Entinostat selectively inhibits class I HDACs, affecting acetylation levels of histones and thereby influencing gene transcription.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$270.00
$465.00
$1607.00
$2448.00
$5239.00
4
(1)

Rocaglamide inhibits translation initiation and could prevent the synthesis of specific oncoproteins, potentially affecting POTEJ expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is a tyrosine kinase inhibitor that can also modulate the activity of various transcription factors, potentially decreasing gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Sirolimus binds to mTOR, indirectly affecting the initiation of mRNA translation and protein synthesis.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin can influence transcription factors, cell cycle proteins, and cytokines, leading to downregulation of some genes.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol activates sirtuins and modulates the activity of transcription factors, possibly leading to reduced gene expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG is known to influence several signaling pathways and could suppress the expression of certain oncogenes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that can block the Akt signaling pathway, potentially leading to decreased protein synthesis.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib inhibits the 26S proteasome, leading to the accumulation of regulatory proteins that could suppress gene expression.